Yes, Thermalytix has been clinically proven for high sensitivity and good specificity. There are 42 peer reviewed publications in top journals and conferences. Some clinical studies and real world evaluations published in top peer reviewed journal publications are listed below.
You can access the full list of Peer-Reviewed Publications about Thermalytix here.
NIRAMAI is the pioneer of a patented technology called Thermalytix© which is a novel fusion of Artificial Intelligence and Breast Thermal Scans. NIRAMAI early stage breast cancer screening solution is a non-contact, non-invasive, portable, safe, automated solution that works for women of all ages. The novel AI and ML algorithms for the analysis of thermal images have resulted in Eleven granted US patents and many more patent applications.
Yes, Thermalytix is different from Thermography. Thermography is visual analysis of thermal images, while Thermalytix uses sophisticated computer aided analysis using artificial intelligence for accurate analysis of thermal maps.
Thermography is an old technique that has been in practise by some medical professionals around the world for analyzing thermal images. It is recommended as an adjunct modality to detect early stage breast cancer. However, manual analysis of thermal images requires highly trained skilled professionals, and many times results in a number of false positives. NIRAMAI’s Thermalytix solution fixes this accuracy issue using machine intelligence and provides an , automated method of quantfying thermal scans, and enabling screening for early stage breast cancer and other breast abnormalities. NIRAMAI Thermalytix has much higher accuracy than Thermography.
There are some important considerations showing why the Niramai solution is not the same as Thermography, and those differences are detailed below:
Thermalytix has regulatory clearance in India, Europe, UAE and Kenya at this time and usage in these countries does not fall under the purview of the above mentioned US FDA warning communication.
While Niramai has not yet applied for US FDA clearance for Thermalytix, Niramai obtained US FDA clearance for our SMILE-100 tool that has subset of features of Thermalytix.
Niramai solution is based on Thermography. Niramai thermal device which is placed 3 feet in front of the patient captures 5 thermal images of the region. Niramai software tool automatically analyses these images and sends the analysis report that is certified by a Senior Radiologist.
For more details, please watch this video https://youtu.be/RT5njRmAdZk
Ideal time period for a woman is from ovulation to the onset of menstruation.
Please click on the link “Register for Screening” and share your details or just drop a note on the contact form with your location and contact details. Our customer support will reach out to you for an appointment in the nearest centre.
Alternatively, you can find a center on Google Map with search keyword “Niramai Breast Clinic near me”. Many of our centers are listed there.
Niramai test is available in 150+ locations in India, Kenya, Philippines, Sweden, Bulgaria, Turkey and UAE.
There is no minimum age for thermographic screening. It doesn’t depend on the age, color, race and density of breast. Any girl post menstruation should be conscious of her breast health.
No. Thermal scanning is a are non-contact, non-invasive and radiation free modality, unlike mammography. Thermal scanners just measures temperature on your skin, there is no harmful radiation exposure too.
Yes. NIRAMAI Thermalytix has received regulatory approval from India, Kenya, UAE, Philippines and all countries in Europe (CE Mark). SMILE-100 (with subset of features of Thermalytix) is regulatory cleared by US FDA.
All Thermal devices used along with Thermalytix software are also US FDA cleared and have European CE Mark.
If you are hospital or diagnostic centre interested in deploying this solution in your centre, please drop a note to email@example.com. We will arrange a free demonstration of the solution and discussion with Niramai BD team. Niramai test is now deployed in 150+reputed hospitals and diagnostic centers such as Apollo Clinics, HCG, Narayana Health and more.
If you are a corporate interested in your employee wellness or an NGO interested in conducting screening camps for women, Niramai solution is available on monthly or daily-rental basis too. Please drop us a note on firstname.lastname@example.org .
For deeper collaboration with Niramai, please write to email@example.com
It depends on how close you are with the relative. If the relative is a first degree relative (Parent, Sibling or Child) you have a more risk of cancer and is recommended to go for frequent screening. If the relative is a second degree relative, the risk is less compared to former.
Early detection is very important to have a good cure. We recommend Thermalytix scan once a year for all females above 25 years. Since Thermalytix give breast health scores, if your score is all zero, you can repeat it once in 2 years, instead.
Patients suffering from fever can postpone their screening to a future date, just to avoide inconvenience to them. Alcoholic beverages should not be consumed for twelve hours prior to the test. Hot tea or coffee should be avoided for at least one full hour before examination. Aspirins, pain medications, vasodilators, constrictors should be avoided for 24 hours prior to test.
While the global guidance advices women above 45 years to take a breast cancer screening test every year, statistics from World Health Organization (WHO) shows that the incidence rates for women below 40 years is also increasing. About 28% of breast cancer deaths are under 45 year. This would worsen in future due to stress, changes in lifestyle and increase in pollution. So, we recommend all women above 25 years to undergo breast screening using radiation-free Thermalytix test at least once. Based on the scoring, we give personalized recommendation on when you need to repeat the test.